Chief Executive Officer, Babylon BioConsulting LLC
Dr. Sam Al-Murrani, CEO, Babylon BioConsulting LLC, a human and animal health-based consultancy firm specializing in pre-revenue and early stage valuations of Animal Health and Biotech companies and providing clients with investor outreach, due diligence, business development and intangible asset management and valuation services. He is also Managing Director for Bimini LLC, a privately owned manufacturer of pet dose-form health supplements and health treats.
He is a recognized expert in his field. A summary of his professional experience can be found on his Linkedin page.
Dr. Al-Murrani has a B.Sc. in Animal Science from the University of Edinburgh and a Ph.D. in Immunology/Biochemistry from the Roslin Institute and the Department of Veterinary Pathology at the University of Edinburgh. He holds an M.B.A. in Finance from Baker University.
Acting Executive Director, Missouri Technology Corporation
State of Missouri
The Missouri Technology Corporation (MTC) is a public-private partnership created by the Missouri General Assembly to promote entrepreneurship and foster the growth of new and emerging high-tech companies. MTC focuses on 21st Century bioscience industries that build on Missouri’s rich history in agriculture.
Director and Professor
Kansas State Veterinary Diagnostic Laboratory
Department of Diagnostic Medicine & Pathobiology
Gary Anderson, director of the Kansas State Veterinary Diagnostic Laboratory, has worked in vaccine research and development for decades. He holds numerous patents, has received several grants and has published more than 60 articles and book chapters.
Anderson's work in bovine health and disease includes serving on the Biologics and Biotechnology, Foreign and Emerging Disease, and National Animal Health Laboratory Network committees of the United States Animal Health Association. He serves as co-chair of the National Animal Health Laboratory Network Coordinating Council.
In addition to his work with cattle, Anderson is involved in swine diagnostics and infectious disease research. He has served on the Transmissible Diseases of Swine Committee of the United States Animal Health Association.
The recent president of the American Association of Veterinary Laboratory Diagnosticians, Anderson serves on the Dean's Administrative Council for the university's College of Veterinary Medicine and on the executive board of the American Association of Veterinary Laboratory Diagnosticians. He also has served on the board of the American Association of Veterinary Immunologists and has been the editor of the group's newsletter. He has been on the editorial boards for the American Journal of Veterinary Research, Veterinary Immunology and Immunopathology journal and the Journal of Immunology.
Corporate Chairman and CEO, ProteaPex Therapeutics
Philadelphia, Pennsylvania Email
Jeff is a serial entrepreneur and investor with over 30 years of global life sciences experience. Jeff’s emerging company and fund raising experience includes startups, growth stage and turnaround in pharmaceuticals, biotechnology, drug delivery, medical devices, and clinical informatics. He is a Business Advisor to university investigators seeking early stage funding from the University City Science Center in Philadelphia. He is Chairman of ProteaPex Therapeutics focused on innovative animal health peptide therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on funding breakthrough technologies.
Vice President, Brakke Consulting, Inc.
John is experienced in worldwide product introductions, sales management, market research, financial and business planning, and providing business valuations. At Brakke Consulting, John concentrates his activities on business analysis, transactions, and recruiting assignments. His financial background makes him the go-to person for evaluations of businesses and technologies that are either looking for a new owner or seeking to enter the market. He provides a quantitative slant on major strategic decisions. John also specializes in recruiting assignments for positions that are particularly difficult to fill. Previous to joining Brakke Consulting, Mr. Mannhaupt held several sales, product management, and marketing positions with Sandoz Corporation, a major pharmaceutical, chemical, and agricultural products firm that is now part of Novartis. John also held corporate financial positions with Occidental Petroleum and General Foods, which is now Kraft. He holds an MBA from the Tepper School of Business at Carnegie-Mellon University and a B.S. in Mathematics from Iona College.
Mark has over 35 years’ experience in the clinical laboratory business with a history of bringing innovative solutions to new business startups. He has held senior level positions in sales, marketing and business development leading to serving as President of his last 2 laboratory startups, both of which were subsidiaries of publicly traded companies. He most recently served as President of Abaxis Veterinary Reference Laboratories which was a collaboration he engineered between Abaxis, the Kansas State College of Veterinary Medicine and his team of laboratory professionals. Prior to that he served as President of Heritage Labs International, a CAP certified laboratory and FDA registered medical device manufacturer that he co-founded in the insurance, wellness and disease management markets. He currently serves on the board of Elias Animal Health and provides consulting services in both the human and veterinary health markets. He has a BA in Biology from Furman University, resides in Scottsdale, AZ and has 2 children, both of whom have 4 legs and bark.
Founding Partner, Cultivian Sandbox Food and Ag Funds I & II
Ron is a founding partner of the Cultivian Sandbox Food and Ag Funds I and II. Ron has over 30 years of experience in bringing new technologies and products to market. He has led research and development for major corporation in agricultural chemicals, field crop and vegetable genetics and breeding, animal health, novel foods and industrial materials. His successful projects include the world’s first field trial of a genetically engineered crop trait in 1986, development and launch of one of the first insect and herbicide resistant corn hybrids in 1996, introduction of a trans-fat free canola oil, and development of dozens of new varieties of field and vegetable crops on three continents. Ron has been a frequent speaker at conferences, a consultant to Federal policy on biotechnology regulatory issues, and active in industry trade groups. Prior to forming Cultivian Ron led the expansion of the biotechnology research and development program of Dow AgroSciences, and founded a successful biopharmaceutical company, Immuneworks, Inc. Ron represents Cultivian on the board of directors of Allylix, Aratana, Proterro and Rivertop Renewables. He was also a member of the board of directors of Divergence, Inc. Divergence was sold to Monsanto Company in February of 2011. Ron holds a Ph.D. from the University of California, Berkeley in plant cell biology, and a bachelor’s degree from the University of Wisconsin, Milwaukee in plant physiology.
Managing Director, Sandbox Industries
Dan Phillips is a Managing Director of Sandbox Industries, where he helps manage the firm's healthcare funds and food & agriculture fund (Cultivian Sandbox). He also helped to build Healthbox, an accelerator program that supports innovative, seed stage healthcare startups. Before joining Sandbox, Dan spent several years in healthcare consulting, most recently as a senior consultant with The Camden Group, where he specialized in hospital strategic planning and service line development.
He also spent a few years with Sg2, a healthcare consulting and thought leadership firm, where he worked with health systems in the UK, Canada, and Southeast Asia. Dan earned his Bachelor of Science degree at the University of Michigan, where he majored in biology.
CEO, Animalytix, LLC
Animalytix® LLC is the animal health industry’s leading provider of geo-located market intelligence. Animalytix sources its sales data from the leading animal health distributors, veterinarians and retailers and maintains a comprehensive database of more than $50 billion in sales history on 15,000+ products from more than 500 manufacturers. Each month, Animalytix publishes a series of syndicated and customized market surveys covering more than 30 unique animal health market segments and provides additional analytical support through a team of Senior Business Advisors, each former operators from the animal health manufacturing or distribution industries.
CEO, BioPharmaPotentials (BPP)
Kansas City, Missouri
Dr. Edward Robb is CEO of BioPharmaPotentials (BPP) an animal health based consultancy that enables its global partners in achieving their extreme potential including technology evaluation, due diligence and assessments of new and repurposed chemical and biologic entities. Services include the execution/conduct of critical Proof of Concept and Proof of Value studies to define value and to provide various opportunity runways. In addition BPP executes clinical efficacy and safety studies in laboratory, target animal and in the clinical setting. BPP develops regulatory and development strategies for small molecules (pharmaceuticals), biologicals (vaccines), medical devises and nutraceuticals. The practice engages on behalf of its clients various public and private funding sources and in the development of manufacturing and quality programs (analytical/formulation development) in concert with the project management to support the technology/product plan. Dr. Robb serves on the Boards of various start-up organizations predominantly in the role as Chief Scientific Officer.
Dr. Robb has a BS in Animal Science, DVM from Cornell University and a Masters in Epidemiology from the University of Pennsylvania; he is a Diplomate of the American College of Veterinary Clinical Nutrition. Dr. Robb has five years of clinical practice and has held various senior leadership positions in Research and Development, Product Development and Business Development at Upjohn, Pharmacia, Pfizer, Embrex, Boehringer Ingelheim Vetmedica, CEVA and Parnell (see Linkedin profile). Dr. Robb’s strong track record for delivering value thru innovation and legacy of leading organizations that achieved game changing registrations and successful commercialization’s spans across specie lines, therapeutic areas, technology platforms and geographies.
Executive Director, Merial Ltd. Atlanta, Georgia
Don Schwartz joined Merck & Co., Inc. as a manager of global marketing communications, rising to his current role as an executive director of Merial’s US Business Operations with responsibilities for business development, market research, regulatory, customer care, veterinary technical solutions, public affairs and business analytical functions. In between, he gained extensive experience in marketing, A&P, product management, finance, manufacturing, media management, packaging development, trademark development and distribution among other business skills. Don was instrumental in the launch of several of his company’s landmark products including IVOMEC, HEARTGARD and FRONTLINE PLUS. He recently led the development of the OraVet line of oral care products.
Don has been the head of a successful advertising and communications agency specializing in pharmaceutical and technical products. He has several books to his credit, including Genus Bos: Cattle Breeds of the World, the standard reference on the subject.
He earned an undergraduate degree in biology from Union College in Schenectady, New York, did graduate work in biology at NYU and has an MS in management from CUNY. Under duress, he will also admit he went to law school.
Partner, Stinson Leonard Street LLP
Andrea is a registered patent attorney with an emphasis in the chemical, biosciences, and animal health fields. She has significant experience in patent prosecution, infringement counseling, and licensing regarding biochemical, chemical, and mechanical inventions. She also has completed extensive reviews and infringement analyses of patents directed to the pharmaceutical, agricultural chemistry, and biochemistry fields. Andrea has developed particular experience in negotiating and drafting intellectual property agreements, including complex technology development and license agreements covering a wide range of technologies.
President & CEO, Shuler Consulting Services
Shuler Consulting Services is focused on working with companies in the area of innovation, planning and execution. SCS has more than 30 years of experience in creating and building successful businesses and developing a strong market position for their products and services. Rich Shuler has worked with businesses, producer organizations, churches and universities to develop long range strategic plans and organizational structure. SCS also assists businesses in acquiring products and technologies that fit the company’s strategic focus.
President, AgTech Advisors, LLC
Tony is the President of AgTech Advisors, LLC, a consulting firm focused on supporting entrepreneurs and investors in the agtech and animal health sectors. Perviously, Tony was a Managing Director for the KBA where he led the KBA’s investment efforts in animal health and agriculture. He has over 22 years’ experience leading businesses in the agriculture, grain processing and renewable fuels industry. He currently serves on the boards of Green Dot Holdings and Advanced Animal Diagnostics and as an observer to the SmartVet board. Prior to joining KBA, Tony lead ED&F Mann’s US ethanol business and spent 9 years with POET, where he started 2 major greenfield ethanol facilities.Tony has also worked in trading and operations roles with Archer Daniels Midland.
Tony holds a BS in economics from Millikin University, Decatur, Ill., an MBA from the University of Minnesota-Minneapolis and attended the Private Equity and Venture Capital Executive Education Program at Harvard.